Citation Impact
Citing Papers
Adaptive Mutations Producing Efficient Replication of Genotype 1a Hepatitis C Virus RNA in Normal Huh7 Cells
2004
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals
2021 StandoutNobel
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
Superinfection Exclusion in Cells Infected with Hepatitis C Virus
2007 StandoutNobel
The Oligoadenylate Synthetase Family: An Ancient Protein Family with Multiple Antiviral Activities
2010
Global Genetic Variation at OAS1 Provides Evidence of Archaic Admixture in Melanesian Populations
2012
Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases
2015
Variation in Antiviral 2′,5′-Oligoadenylate Synthetase (2′5′AS) Enzyme Activity Is Controlled by a Single-Nucleotide Polymorphism at a Splice-Acceptor Site in the OAS1 Gene
2005
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING
2013 StandoutNature
Genetic modifiers of non-alcoholic fatty liver disease progression
2011
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Coinfection With HIV-1 and HCV—A One-Two Punch
2009
T‐cell exhaustion: characteristics, causes and conversion
2010
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
TLR4 enhances TGF-β signaling and hepatic fibrosis
2007 Standout
Hepatocellular carcinoma
2012 Standout
Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus
2008
Immunology of hepatitis B virus and hepatitis C virus infection
2005 Standout
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Silencing of USP18 Potentiates the Antiviral Activity of Interferon Against Hepatitis C Virus Infection
2006 StandoutNobel
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
2020
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man
2009
A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C†
2007
Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study
2006
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
2009
Non-alcoholic fatty liver disease
2021 Standout
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
2007
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy
2010
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin
2015 StandoutNobel
Remodelling the extracellular matrix in development and disease
2014 Standout
Prognostic models including the Child–Pugh, MELD and Mayo risk scores—where are we and where should we go?
2004
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Hepatic Gene Expression Discriminates Responders and Nonresponders in Treatment of Chronic Hepatitis C Viral Infection
2005
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Synergistic up‐regulation of MCP‐2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti‐tumoral effects
2009
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment
2011
The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection
2007
Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3
2005 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection
2007
Hepatocellular Carcinoma
2011 Standout
Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs
2003
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
2016 StandoutNatureNobel
Interferon-inducible antiviral effectors
2008 Standout
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C†
2004
Replication of hepatitis C virus
2007 StandoutNobel
Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host
2012 StandoutNobel
Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C
2005 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
2012
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Antiviral Stilbene 1,2-Diamines Prevent Initiation of Hepatitis C Virus RNA Replication at the Outset of Infection
2011 StandoutNobel
Multi-State Models for Panel Data: ThemsmPackage forR
2011 Standout
The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication
2007 StandoutNobel
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
2005 StandoutScience
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Viral Determinants of Resistance to Treatment in Patients with Hepatitis C
2007
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
2010 StandoutNobel
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
NSs Protein of Rift Valley Fever Virus Induces the Specific Degradation of the Double-Stranded RNA-Dependent Protein Kinase
2009
Mutations Conferring Resistance to a Potent Hepatitis C Virus Serine Protease Inhibitor In Vitro
2004
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
In Vitro Selection and Characterization of Hepatitis C Virus Serine Protease Variants Resistant to an Active-Site Peptide Inhibitor
2003
Current status of novel antifibrotic therapies in patients with chronic liver disease
2011
Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection
1999
Works of Mark Wright being referenced
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR
2003
Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection
2002
Influence of IL‐10RA and IL‐22 polymorphisms on outcome of hepatitis C virus infection
2007
Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment
2006
Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection
2003
Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection
2003
Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies
2008
Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease
2018
Association of Genetic Variants of the Chemokine Receptor Ccr5 and Its Ligands, Rantes and Mcp–2, With Outcome of Hcv Infection
2003
Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study
2003
Parenchymal Extinction: Coagulation and Hepatic Fibrogenesis
2009
Treatment of Chronic Viral Hepatitis
2001